Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/174730
Title: Epidemic and pandemic viral infections: impact on tuberculosis and the lung: a consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC)
Author: Ong, Catherine Wei Min
Migliori, Giovanni Battista
Raviglione, Mario
MacGregor-Skinner, Gavin
Sotgiu, Giovanni
Alffenaar, Jan-Willem
Tiberi, Simon
Adlhoch, Cornelia
Alonzi, Tonino
Archuleta, Sophia
Brusin, Sergio
Cambau, Emmanuelle
Capobianchi, Maria Rosaria
Castilletti, Concetta
Centis, Rosella
Cirillo, Daniela Maria
D'Ambrosio, Lia
Delogu, Giovanni
Esposito, Susanna M.R.
Figueroa, Jose
Friedland, Jon S.
Heng, Benjamin Choon Ho
Ippolito, Giuseppe
Jankovic, Mateja
Kim, Hannah Yejin
Klintz, Senia Rosales
Ködmön, Csaba
Lalle, Eleonora
Leo, Yee Sin
Leung, Chi-Chiu
Märtson, Anne-Grete
Melazzini, Mario Giovanni
Fard, Saeid Najafi
Penttinen, Pasi
Petrone, Linda
Petruccioli, Elisa
Pontali, Emanuele
Saderi, Laura
Santín Cerezales, Miguel
Spanevello, Antonio
Keywords: Infeccions respiratòries
Epidemiologia
Tuberculosi
Malalties víriques
Respiratory infections
Epidemiology
Tuberculosis
Virus diseases
Issue Date: 1-Oct-2020
Publisher: European Respiratory Society
Abstract: Major epidemics, including some that qualify as pandemics, such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), HIV, influenza A (H1N1)pdm/09 and most recently COVID-19, affect the lung. Tuberculosis (TB) remains the top infectious disease killer, but apart from syndemic TB/HIV little is known regarding the interaction of viral epidemics and pandemics with TB. The aim of this consensus-based document is to describe the effects of viral infections resulting in epidemics and pandemics that affect the lung (MERS, SARS, HIV, influenza A (H1N1)pdm/09 and COVID-19) and their interactions with TB. A search of the scientific literature was performed. A writing committee of international experts including the European Centre for Disease Prevention and Control Public Health Emergency (ECDC PHE) team, the World Association for Infectious Diseases and Immunological Disorders (WAidid), the Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycobacterial Infections (ESGMYC) was established. Consensus was achieved after multiple rounds of revisions between the writing committee and a larger expert group. A Delphi process involving the core group of authors (excluding the ECDC PHE team) identified the areas requiring review/consensus, followed by a second round to refine the definitive consensus elements. The epidemiology and immunology of these viral infections and their interactions with TB are discussed with implications for diagnosis, treatment and prevention of airborne infections (infection control, viral containment and workplace safety). This consensus document represents a rapid and comprehensive summary on what is known on the topic.
Note: Reproducció del document publicat a: https://doi.org/10.1183/13993003.01727-2020
It is part of: European Respiratory Journal, 2020, vol. 56, num. 4, p. 2001727
URI: http://hdl.handle.net/2445/174730
Related resource: https://doi.org/10.1183/13993003.01727-2020
ISSN: 0903-1936
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Ciències Clíniques)

Files in This Item:
File Description SizeFormat 
705437.pdf7.36 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons